Incidence and prognosis in early onset breast cancer.

The aim of this study was to assess the incidence and prognosis in early onset breast cancer. Age-adjusted incidence and death rate for the 5394 Swedish women diagnosed with breast cancer under the age of 40 between 1960 and 1996 was studied using data from the Swedish Cancer Registry and Swedish Death Cause Registry. A total of 107 consecutive young patients with invasive breast cancer undergoing surgery during 1980-1993 in the Southeast Swedish health care region were retrospectively followed up and their cancers reviewed and graded blindly. The median follow-up time was 11.2 years. The applicability of the Nottingham Prognostic Index (NPI) as a prognostic tool was investigated. Grade, age, node status, tumour size, S-phase fraction and steroid receptor content were related to survival univariately and multivariately in a Cox proportional hazard analysis. The incidence of early onset breast cancer has increased moderately and the survival rate has not improved during the last 35 years. When young women are diagnosed with breast cancer their tumours are larger, their lymph nodes more often involved, and the median grade higher than in older with 64% having grade 3 tumours. Lymph node status was the strongest sole prognostic indicator but the use of NPI gave more accurate prognostic information than node status alone.

[1]  D. Cox.  Regression Models and Life-Tables , 1972 .

[2]  T. Möller,et al.  Validity of breast cancer registration from one hospital into the Swedish National Cancer Registry 1971-1991. , 1995, Acta oncologica.

[3]  G M Lenoir,et al.  Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage , 1996, Cancer.

[4]  R. Millikan,et al.  Studying environmental influences and breast cancer risk: suggestions for an integrated population-based approach , 1995, Breast Cancer Research and Treatment.

[5]  R. Blamey,et al.  Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐up , 1992, Histopathology.

[6]  S. Romain,et al.  Clinical and Biologic Prognostic Factors in Breast Cancer Diagnosed During Postmenopausal Hormone Replacement Therapy , 1995, Obstetrics and gynecology.

[7]  B. Caballero,et al.  High bone mass as a marker for breast cancer risk. , 2009, Nutrition reviews.

[8]  I. Ellis,et al.  Early-onset breast cancer--histopathological and prognostic considerations. , 1997, British Journal of Cancer.

[9]  A. Sasco,et al.  Impact of menopausal hormone‐replacement therapy on clinical and laboratory characteristics of breast cancer , 1998, International journal of cancer.

[10]  G. Colditz,et al.  Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  B. Agnarsson,et al.  Inherited BRCA2 mutation associated with high grade breast cancer , 2004, Breast Cancer Research and Treatment.

[12]  M. Stratton.  Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.

[13]  J. Cuzick,et al.  Hormone replacement therapy and biological aggressiveness of breast cancer , 1997, The Lancet.

[14]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[15]  David L. Page,et al.  Diagnostic Histopathology of the Breast , 1988 .

[16]  P. Tartter,et al.  Carcinoma of the breast in postmenopausal hormone user and nonuser control groups. , 1994, Journal of the American College of Surgeons.

[17]  D. Birnbaum,et al.  Mutations at BRCA1: the medullary breast carcinoma revisited. , 1998, Cancer research.

[18]  Helena R. Chang,et al.  Younger women with breast carcinoma have a poorer prognosis than older women , 1996, Cancer.

[19]  M. J. van de Vijver,et al.  Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. , 1998, International journal of radiation oncology, biology, physics.

[20]  Sten Thorstenson,et al.  Applying the Nottingham Prognostic Index to a Swedish breast cancer population , 2004, Breast Cancer Research and Treatment.

[21]  J. Huff,et al.  Breast cancer and environmental risk factors: epidemiological and experimental findings. , 1996, Annual review of pharmacology and toxicology.

[22]  V. Bardou,et al.  Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: a 10-year follow-up. , 1998, International journal of radiation oncology, biology, physics.

[23]  L. Rutqvist,et al.  Inconsistencies in breast carcinoma registration. An investigation of 855 cases reported to the Swedish Cancer Registry. , 1983, Acta radiologica. Oncology.

[24]  P. Borgen,et al.  Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. , 1998, Journal of the American College of Surgeons.

[25]  L. Belghiti,et al.  Prognostic factors in breast cancer , 2002 .

[26]  J. Boccio,et al.  Computer program manual , 1972 .

[27]  K. Aspegren,et al.  Breast cancer as cause of death--a study over the validity of the officially registered cause of death in 2631 breast cancer patients dying in Malmö, Sweden 1964-1992. , 1996, Acta oncologica.

[28]  R. Coates,et al.  Prenatal and Perinatal Risk Factors for Breast Cancer in Young Women , 1997, Epidemiology.

[29]  H. Adami,et al.  PROGNOSIS AFTER BREAST CANCER DIAGNOSIS IN WOMEN EXPOSED TO ESTROGEN AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY , 1989 .

[30]  L Piana,et al.  Age as a prognostic factor in breast cancer: Relationship to pathologic and biologic features , 1995, International journal of cancer.

[31]  J. Hansen.  Breast cancer risk among relatively young women employed in solvent-using industries. , 1999, American journal of industrial medicine.

[32]  D. Page,et al.  Pathology and heredity of breast cancer in younger women. , 1994, Journal of the National Cancer Institute. Monographs.

[33]  B. Asselain,et al.  Age as prognostic factor in premenopausal breast carcinoma , 1993, The Lancet.

[34]  S. Steinberg,et al.  Breast cancer in young women: clinicopathologic correlation. , 1999, Seminars in diagnostic pathology.

[35]  S. Pinder,et al.  Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma , 1995, Histopathology.